Insulin lispro

This classification denotes a therapeutic insulin with the molecular formula C257H383N65O77S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GFX7QIS1II, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears US NIH Compound Identifier 16129672. European Medicines Agency schedules Insulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02689MIG. The term INSULIN is an International Non-Proprietary Name WHO schedules insulin in its Anatomical Therapeutic Chemical (ATC) Classification. INSULIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule insulin lispro under HS 29349990 and SITC 51579. Insulin lispro bears US NLM identifiers UMLS ID C0293359 and NCI Concept Code C29123. SMILES: As of Q4 2014, INSULIN LISPRO remains US FDA's Preferred Term for this commodity.